News & Updates
Filter by Specialty:
Opioid use ups healthcare use, costs in adults with PsA, AS
Patients with psoriatic arthritis (PsA) and ankylosing spondylitis (AS) who use opioids end up with higher healthcare utilization and costs compared with those who do not use opioids, reports a study.
Opioid use ups healthcare use, costs in adults with PsA, AS
24 Oct 2024
Semaglutide helps prevent HF events, CV death in diabetic patients with CKD
Treatment with semaglutide can significantly lower the risk of time to first heart failure (HF) events or cardiovascular (CV) death in type 2 diabetes (T2D) patients with chronic kidney disease (CKD), a recent study has shown.
Semaglutide helps prevent HF events, CV death in diabetic patients with CKD
24 Oct 2024
Statins may prevent deaths in hospitalized COVID-19 patients
Use of statins helps prevent deaths in patients hospitalized with COVID-19, as shown by the results of a systematic review and meta-analysis.
Statins may prevent deaths in hospitalized COVID-19 patients
22 Oct 2024
DISCREET highlights apremilast potential for genital psoriasis
Individuals with psoriasis creeping into their intimate areas may find relief from apremilast, as shown by the week-32 improvements in multiple disease parameters in the phase III DISCREET study.
DISCREET highlights apremilast potential for genital psoriasis
22 Oct 2024
Induction chemo followed by chemoradiotherapy bumps up survival in advanced cervical cancer
A short-course induction chemotherapy conducted prior to chemoradiotherapy appears to deliver significant survival boost in locally advanced cervical cancer, according to the phase III GCIG INTERLACE trial.
Induction chemo followed by chemoradiotherapy bumps up survival in advanced cervical cancer
21 Oct 2024
IV iron replacement safe, effective for anemia after variceal bleed in cirrhosis patients
Patients with cirrhosis with iron deficiency anemia after variceal bleed (VB) can rely on the efficacy and safety of intravenous (IV) iron replacement, reports a study.
IV iron replacement safe, effective for anemia after variceal bleed in cirrhosis patients
21 Oct 2024
TIL therapy still effective in advanced melanoma despite prior anti-PD-(L)1 treatment
The clinical response or survival benefit derived by patients with advanced cutaneous melanoma from adoptive cell therapy with tumor-infiltrating lymphocytes (TIL-ACT) does not wane even with prior antiprogrammed cell death protein 1/programmed death-ligand 1 (anti-PD-[L]1) treatment, according to a study. TIL therapy also provides benefits in the second-line setting after anti-PD-(L)1 treatment.